PCI Biotech (Norway) Market Value
| PCIB Stock | NOK 1.90 0.58 43.94% |
| Symbol | PCI |
PCI Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PCI Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PCI Biotech.
| 08/28/2024 |
| 11/26/2024 |
If you would invest 0.00 in PCI Biotech on August 28, 2024 and sell it all today you would earn a total of 0.00 from holding PCI Biotech Holding or generate 0.0% return on investment in PCI Biotech over 90 days. PCI Biotech is related to or competes with DnB ASA, Storebrand ASA, Sparebank, Telenor ASA, Sparebanken Vest, Sparebank, and Norsk Hydro. PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapie... More
PCI Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PCI Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PCI Biotech Holding upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.55 | |||
| Information Ratio | 0.0317 | |||
| Maximum Drawdown | 17.11 | |||
| Value At Risk | (5.96) | |||
| Potential Upside | 7.14 |
PCI Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PCI Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PCI Biotech's standard deviation. In reality, there are many statistical measures that can use PCI Biotech historical prices to predict the future PCI Biotech's volatility.| Risk Adjusted Performance | 0.0478 | |||
| Jensen Alpha | 0.1235 | |||
| Total Risk Alpha | (0.71) | |||
| Sortino Ratio | 0.0469 | |||
| Treynor Ratio | 0.189 |
PCI Biotech Holding Backtested Returns
PCI Biotech appears to be extremely dangerous, given 3 months investment horizon. PCI Biotech Holding maintains Sharpe Ratio (i.e., Efficiency) of 0.0407, which implies the company had a 0.0407% return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for PCI Biotech Holding, which you can use to evaluate the volatility of the entity. Please evaluate PCI Biotech's coefficient of variation of 1964.59, and Market Risk Adjusted Performance of 0.199 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PCI Biotech holds a performance score of 3. The firm holds a Beta of 1.76, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PCI Biotech will likely underperform. Please check PCI Biotech's jensen alpha, sortino ratio, and the relationship between the standard deviation and total risk alpha , to make a quick decision on whether PCI Biotech's historical price patterns will revert.
Auto-correlation | 0.18 |
Very weak predictability
PCI Biotech Holding has very weak predictability. Overlapping area represents the amount of predictability between PCI Biotech time series from 28th of August 2024 to 12th of October 2024 and 12th of October 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PCI Biotech Holding price movement. The serial correlation of 0.18 indicates that over 18.0% of current PCI Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
PCI Biotech Holding lagged returns against current returns
Autocorrelation, which is PCI Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PCI Biotech's stock expected returns. We can calculate the autocorrelation of PCI Biotech returns to help us make a trade decision. For example, suppose you find that PCI Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
PCI Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PCI Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PCI Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PCI Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
PCI Biotech Lagged Returns
When evaluating PCI Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PCI Biotech stock have on its future price. PCI Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PCI Biotech autocorrelation shows the relationship between PCI Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in PCI Biotech Holding.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in PCI Stock
PCI Biotech financial ratios help investors to determine whether PCI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PCI with respect to the benefits of owning PCI Biotech security.